Effect of Tenofovir With and Without Interferon on Hepatitis D Virus Replication in HIV–Hepatitis B Virus–Hepatitis D Virus-Infected Patients
✍ Scribed by Boyd, Anders; Miailhes, Patrick; Brichler, Ségolène; Scholtès, Caroline; Maylin, Sarah; Delaugerre, Constance; Chevallier-Queyron, Phillipe; Gordien, Emmanuel; Girard, Pierre-Marie; Lacombe, Karine
- Book ID
- 121872189
- Publisher
- Mary Ann Liebert
- Year
- 2013
- Tongue
- English
- Weight
- 173 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0889-2229
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Hepatitis D virus and hepatitis B virus nucleic acids were detected by Northern and Southern blot hybridization in the sera and livers of 86 chronic carriers of HBsAg and anti-hepatitis D followed up for a mean of 10 yr. We identified three subsets of patients 13 with hepatitis D virus and hepatitis
for the TECOVIR Study Group Tenofovir disoproxil fumarate (TDF) has shown in vitro activity against both HIV and hepatitis B virus (HBV). We retrospectively evaluated the efficacy of TDF (300 mg/d), administered as a part of anti-retroviral therapy, in a large cohort of HIV/HBV-coinfected patients.
W e evaluated hepatitis B virus DNA and hepatitis C virus RNA in sera from 110 HBsAg and IgM HBc antibody-negative heavy drinkers (50 cirrhosis, 13 chronic active hepatitis, 25 fatty liver with or without mild to moderate fibrosis, alcoholic hepatitis or both and 22 healthy alcoholic subjects) with